Plastics firm Ensinger acquires medtech player Moll

Plastics processor Ensinger has taken over the medical technology manufacturer Moll Engineering. The owner-operated company based in Lübeck manufactures products from carbon fibre-reinforced high-performance plastics, stainless steel and titanium.

Moll’s core specialism lies in target devices for trauma surgery, retractors and other medical instruments. They also work on components for automation technology and aviation round off its portfolio. Moll’s surgical instruments from hybrid materials is said to complement Essinger’s portfolio.

The acquisition also includes the takeover of the manufacturing company Wenglon, which makes products on Moll’s behalf in Dobra, near Szczecin, Poland. Engineering and Sales are based at the Lübeck site. A total of 70 employees work for Moll and Wenglon.

Dr Roland Reber, managing director at Ensinger, said: “We are delighted about this new addition, which introduces an attractive technology range into the corporate group. The combination of carbon fibre-reinforced plastics and metals is the ideal solution for many medical applications, particularly in orthopaedics and trauma surgery.”

Ensinger already develops plastic compounds for the medical technology sector, provides stock shapes made from carbon fibre composite and other materials, and produces machined parts, for example trial implants and sterilisable cases and trays. Besides, a subsidiary company is developing new technologies for the processing of thermoplastic fibre composites. The different process technologies open up diverse options for customers for developing and manufacturing products together with Ensinger along the value-added chain.

Stefan Moll, co-founder of Moll Engineering, who will continue to be in charge of the company said: “The wide platform offers the company, and my employees, good prospects for the future.”

Moll is to keep its headquarters in Lübeck, and there are further investments planned for the manufacturing in Dobra.